LQT and Smartphone/Smartwatch

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

111 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-03-22

Study Completion Date

2023-06-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Congenital long QT syndrome (LQTS) is a rare genetic disorder characterized by prolongation of the corrected QT interval (QTc) on the electrocardiogram. LQTS is associated with a risk of syncope or sudden death from ventricular arrhythmia.

The increase in the duration of the corrected QT interval and / or changes in the morphology of the T wave on the electrocardiogram are markers of an increased risk of sudden death and syncope.

Recently, a personal portable 6-lead device (DI, DII, DIII, aVF, aVL and aVR) connected to the patient's smartphone has entered the market (KARDIA MOBILE 6L, AliveCor, Mountain View, CALIFORNIA, USA). The APPLE WATCH Series 6 (Apple, Cupertino, CA, USA) can also record an ECG. If the device is designed to record a single lead (DI), several works have shown that it is possible to record 9 leads (DI, DII, DIII, V1, V2, V3, V4, V5 and V6) by moving simply the device (Spaccarotella CAS et al. JAMA Cardiology 2020).

These devices were originally designed to screen for atrial fibrillation, but they produce accurate 6- and 9-lead ECGs and could potentially allow ambulatory ECG monitoring of patients with LQTS.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Comparison Between Epinephrine and Exercise Test in QT Long Syndrome Patients

NCT01745666

Long QT Syndrome Type 1 or 2

UNKNOWN NA

Prevalence of Congenital Long QT Syndrome and Acquired QT Prolongation in a Hospital Cohort

NCT03544918

Long QT Syndrome

COMPLETED

Cardiac Rehabilitation of Children and Adolescent With Long QT Syndrome

NCT05964322

Long QT Syndrome Congenital Long Qt Syndrome Inherited Cardiac Conduction Disorder +1 more

COMPLETED

Electromechanical Profiling of the Long-QT Syndrome (LQTS)

NCT04074122

Long QT Syndrome Sudden Cardiac Death Ventricular Tachycardia

UNKNOWN

Development of an Artificial Intelligence Algorithm to Detect Pathological Repolarization Disorders on the ECG and the Risk of Ventricular Arrhythmias

NCT05829993

Cardiac Disease Ventricular Arrythmia

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Long QT Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

LQT

Patients with LQT syndrome diagnosis.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Patient with diagnosis of LQTS based on the following criteria:

* Corrected QT (Qtc) interval according to Bazett method ≥ 480 ms, at several times in the absence of a secondary cause
* and / or class 4 or 5 mutation in a gene involved in long QT syndrome
* and / or syncope (s) and QTc\> 460ms in the absence of other cause

* All ages
* No opposition from the patient